Tag: pharmaceutical industry

midcap stocks: Is it time to make that tactical allocation back to midcaps?

Before Sebi came up with the market-cap categorisation guidelines in order to ensure uniformity with respect to the investment universe of equity mutual fund schemes,...

For India, 2020 will be known as year of internal discovery: PM Modi | India News

NEW DELHI: The Covid-19 pandemic has brought to the fore India’s national character for the entire world to behold and 2020 will be known as...

European Union plans easier access to generics in potential blow to big drugmakers

BRUSSELS: The European Commission wants to make it easier for patients to access cheaper, generic medicines, a draft EU document seen by Reuters shows, in...

Warren Buffett: Warren Buffett’s firm buying big into drug stocks. Should you too?

NEW DELHI: Legendary investor Warren Buffett‘s Berkshire Hathaway has invested in four large drugmakers in the recent months. Latest investment data showed the Nebraska-based company...

Gland pharma IPO review: Gland Pharma’s Rs 6,480 crore IPO kicks off: Should you subscribe?

NEW DELHI: India’s largest pharmaceutical IPO by Gland Pharma hit the primary market on Monday. The Rs 6,480 crore issue is being sold in Rs...

Nifty: Dalal Street week ahead: Bulls are in charge, but remain stock specific

The week gone by saw the domestic equity indices move in a wide range and stocks rally on global risk-on sentiment following the US election...

chemical industry: Diversified product portfolio to reduce Covid-19 slowdown impact on chemical players: Icra

MUMBAI: With most basic chemical and petrochemical players having a diverse range of end-user industries, the impact of Covid-19 slowdown is likely to be moderated,...

Nifty: Nifty overbought, market may see sectoral rotation in the near term

The domestic equity market took a breather during the week gone by after registering a steep one-day drop in the previous week. FPIs and DIIs...

UAE to provide incentives to Indian healthcare firms with strong R&D facilities: Envoy

The UAE government will provide incentives, including financial contributions, and will make efforts to create a full ecosystem to support Indian healthcare manufacturing companies having...

pharmaceutical industry: Why are investors chasing only equities in a pandemic-hit market?

MUMBAI: There are quite a few companies whose business model got a boost due to Covid-19, said Ajay Saraf, head of investment banking & institutional...

Surge in equities driven by expectations of V-shaped recovery in FY22: A Balasubramanian

Equity markets are being fuelled by investors’ confidence in the Indian economy over a longer term and it is this buying amid easy liquidity which...

Millennials: Is passive investing the best way for millennials to enter the market?

For us, it has been about bringing good innovative products to the market. We deal in both passive or active baskets, says Radhika Gupta, MD...

Pharma unlikely to see steep rally ahead, better to exit: Anand Tandon

To think that pharma can continue to go the same way, especially after the kind of steep rally it has seen, is being overly bullish,...

Bigger money will be made in top 4 private banks over next 12 months: Aditya Khemani

We continue to be positive on the market and these corrections in our view would be bought into by people who are on the sidelines,...

DCGI orders Serum Institute of India to suspend recruitment for Oxford Covid-19 vaccine trials | India News

NEW DELHI: Drugs controller general of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and...

Why a bull run in Covid-damaged sectors is likely in 1-3 years

There are deep value opportunities in utilities and manufacturing sectors and a big rerating for these sectors is possible over the next one to three...

Why is Sensex rising: Bank stocks, RIL lift Sensex 450 points; Nifty near 11,800

NEW DELHI: Riding on the euphoria over a big-bang deal that promises to change India’s retailing sector, Street bulls pumped money into stock markets on...

India’s export uptick led by East Asian economies; China leads with 78% growth: Report

MUMBAI: The massive improvement in the country’s export numbers in July is led by a full 78 per cent spike in shipments to China and...

India, China have agreed to disengagement, de-escalation process, it is work in progress: Jaishankar | India News

NEW DELHI: External Affairs Minister S Jaishankar on Saturday said that India and China have agreed to disengagement along the LAC in Eastern Ladakh and...

Over half of Indian firms ‘vulnerable’ on wage payments: Crisil

Mumbai: Over half of Indian companies are “vulnerable” from a wage payments perspective, which will lead to a sharp cut in paychecks and delay the...

Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar class

Mumbai: French drugmaker Sanofi and Regeneron of the US halted their clinical trials of rheumatoid arthritis drug Sarilumab after finding it did not improve the...

Boycott China: Checks on imports to hit drug, devices supply

New Delhi: Delays in clearing import consignments from China at India’s ports and airports may soon hit the pharmaceutical sector, creating shortages and increasing costs....

Jobs: Revival sign: Hiring up in some sectors

MUMBAI: In signs of revival, hiring has picked up in select sectors and profiles. Industry experts said over the last couple of weeks, they have...

View: With the global supply chain being reconfigured, India must intelligently restructure its economy

By N Venkatram Covid-19 has changed our collective calculus of uncertainty. It is more global in scope, more profoundly impactful, and much more complex than...

​US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

NEW DELHI: US pharmaceutical giant Gilead Sciences is likely to apply to India’s Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its...